Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

104.95
Delayed Data
As of Dec 07
 -0.51 / -0.48%
Today’s Change
92.28
Today|||52-Week Range
157.99
-32.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues258.3M265.1M233.8M228.8M
 
 
 
 
 
Cost of Goods Sold40.6M37.2M47.2M47.7M
 
 
 
 
 
Depreciation And Amortization3.5M3.5M3.7M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income214.2M224.3M182.9M177.4M
 
 
 
 
 
General Expenses40.8M42.5M40.2M35.7M
 
 
 
 
 
Research And Development17.9M19.9M17.9M14.8M
 
 
 
 
 
Total Operating Expenses85.0M83.3M91.1M87.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income173.4M181.8M142.7M141.6M
 
 
 
 
 
Extraordinary Credit27.0K0.000.000.00
 
 
Extraordinary Charge---95.0K-108.0K-76.0K
 
 
 
 
Other Expenses24.6M-46.6M-2.2M18.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income201.0M138.0M140.4M159.5M
 
 
 
 
 
Income Taxes-11.8M-23.0M-30.4M-35.6M
 
 
 
 
 
Minority Interest-98.0K-65.0K-4.0K-243.0K
 
 
 
 
 
Discontinued Operations-101.0K-34.0K-101.0K-76.0K
 
 
 
 
 
Net Income189.0M115.0M109.9M123.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M42.4M41.3M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M42.4M41.3M
 
 
 
 
 
 
Earnings Per ShareEPS$4.41$2.68$2.59$3.00
 
 
 
 
 
EPS Diluted$4.41$2.68$2.59$2.99